Pfizer Inc (PFE)

Return on assets (ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	8,031,000	2,119,000	31,372,000	21,979,000	7,020,000
Total assets	US$ in thousands	213,396,000	226,501,000	197,206,000	181,477,000	154,229,000
ROA		3.76%	0.94%	15.91%	12.11%	4.55%

December 31, 2024 calculation

ROA = Net income ÷ Total assets
= $8,031,000K ÷ $213,396,000K
= 3.76%

Based on the data provided, Pfizer Inc's return on assets (ROA) has fluctuated over the last five years.

- As of December 31, 2020, Pfizer's ROA was 4.55%, indicating that the company generated $0.0455 in net income for every dollar of assets it had.
- By December 31, 2021, the ROA had significantly increased to 12.11%, suggesting improved efficiency in generating earnings from its assets.
- The trend continued to improve in 2022, with the ROA reaching 15.91%, indicating a strong performance in utilizing its assets to generate profits.
- However, there was a sharp decline in ROA by December 31, 2023, where it dropped to 0.94%, indicating a lower profitability relative to its assets during that period.
- By December 31, 2024, the ROA increased to 3.76%, showing some recovery but still below the levels seen in 2022.

Overall, Pfizer's ROA has shown variability, with periods of strong performance in asset utilization for generating profits but also experiencing fluctuations that impacted its overall return on assets. It will be essential for Pfizer to assess and address factors contributing to these fluctuations to maintain and improve its profitability in the future.